More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...
The prognosis of patients with glioblastoma ... antibody array R&D Systems ARY001 Detects the relative phosphorylation of 42 different receptor tyrosine kinases 9 Panorama antibody microarray ...
Tocilizumab, an anti–IL-6 receptor monoclonal antibody, is typically used to manage CRS, whereas corticosteroids may also be used to suppress the immune reaction. CRS and neurotoxicity occur when ...
Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei 110, Taiwan International Master Program in ...
This research was supported by National Institutes of Health (NIH) Grant NS 20023 and Grant CA 11898 and by NIH Grant MO1 RR30, General Clinical Research Centers Program, National Center for ...
Given that VPA can cross the blood-brain barrier, we investigated the effect of VPA on the expression of surface NKG2D ligands in glioma cell lines and attempted to combine VPA and NKG2D CAR-T to ...
Dipotassium glycyrrhizinate (DPG, C 42 H 60 K 2 O 16), a dipotassium salt of glycyrrhizic acid (C 42 H 62 O 16) isolated from licorice (Glycyrrhiza glabra), has recently demonstrated an anti-tumoral ...
Domvanalimab is under development for the treatment of non-small cell lung cancer (first line), glioblastoma multiforme (GBM), recurrent ... The therapeutic candidate is a monoclonal antibody which ...
Domvanalimab is under clinical development by Arcus Biosciences and currently in Phase I for Recurrent Glioblastoma Multiforme (GBM ... known as A2aR and A2bR in combination with anti-PD-1 antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback